| Literature DB >> 32194171 |
Chuanqi Peng1, Yingyu Huang1, Jie Zheng2.
Abstract
Physiological barriers encountered in the clinical translation of cancer nanomedicines inspire the community to more deeply understand nano-bio interactions in not only tumor microenvironment but also entire body and develop new nanocarriers to tackle these barriers. Renal clearable nanocarriers are one kind of these newly emerged drug delivery systems (DDSs), which enable drugs to rapidly penetrate into the tumor cores with no need of long blood retention and escape macrophage uptake in the meantime they can also enhance body elimination of non-targeted anticancer drugs. As a result, they can improve therapeutic efficacies and reduce side effects of anticancer drugs. Not limited to anticancer drugs, diagnostic agents can also be achieved with these renal clearable DDSs, which might also be applied to improve the precision in the gene editing and immunotherapy in the future.Entities:
Keywords: Cancer; Drug delivery; Nanocarriers; Nanomedicine; Nanoparticle; Physiological barriers; Renal clearance
Mesh：
Substances：
Year: 2020 PMID： 32194171 PMCID： PMC8696951 DOI： 10.1016/j.jconrel.2020.03.020
Source DB: PubMed Journal: J Control Release ISSN： 0168-3659 Impact factor: 9.776